A
CVS icon

AustralianSuper’s CVS Health CVS Stock Holding History

AustralianSuper’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-182,824
Closed -$13.1M – 301
2026
Q1 		$13.1M Sell
182,824
-17,852
-9% -$1.38M 0.07% 167
2025
Q4 		$15.9M Hold
200,676
– – 0.07% 155
2025
Q3 		$15.1M Sell
200,676
-492,309
-71% -$33.7M 0.07% 162
2025
Q2 		$47.8M Sell
692,985
-105,918
-13% -$6.95M 0.24% 95
2025
Q1 		$54.1M Sell
798,903
-486,331
-38% -$29.1M 0.31% 88
2024
Q4 		$57.7M Sell
1,285,234
-252,557
-16% -$14.2M 0.27% 93
2024
Q3 		$96.7M Buy
1,537,791
+151,901
+11% +$8.86M 0.48% 62
2024
Q2 		$81.9M Buy
1,385,890
+316,145
+30% +$19.8M 0.47% 62
2024
Q1 		$85.1M Buy
1,069,745
+136,179
+15% +$10.4M 0.5% 64
2023
Q4 		$73.7M Buy
933,566
+252,042
+37% +$17.9M 0.44% 60
2023
Q3 		$47.6M Buy
681,524
+49,149
+8% +$3.48M 0.31% 81
2023
Q2 		$43.7M Buy
+632,375
New +$45M 0.28% 81

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AustralianSuper's CVS Position: Q2 2026 in Review

AustralianSuper sold out of CVS Health (CVS) in Q2 2026, closing a stake of 182,824 shares — an estimated $13.1M sold.

AustralianSuper first reported a position in CVS in Q2 2023 and held it in 12 quarters. The position peaked at $96.7M in Q3 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • AustralianSuper reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • AustralianSuper sold 182,824 CVS Health shares in Q2 2026, an estimated $13.1M.
  • AustralianSuper first reported a position in CVS Health in Q2 2023 and held it in 12 quarters.
  • AustralianSuper's CVS Health position peaked at $96.7M in Q3 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on AustralianSuper's 13F filing for Q2 2026, filed 12 Aug 2026.